Results 281 to 290 of about 218,068 (352)

Treatment-related mutagenic processes in acute lymphoblastic leukemia. [PDF]

Haematologica
Van der Ham CG, Van Leeuwen FN, Kuiper RP.   +2 more
europepmc   +1 more source

V-H gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia [PDF]

, 2003
Amlot, P, Duke, VM, Foroni, L, Gandini, D, Heelan, B, Hoffbrand, AV, Lin, K, Mehta, AB, Sherrington, PD   +8 more
core  

Germline variants observed in pediatric cancer patients related to hereditary breast and ovarian cancer in adults

International Journal of Cancer, Volume 157, Issue 12, Page 2447-2454, 15 December 2025.
What's New? Investigating the spectrum of (likely) pathogenic germline variants (LP/PVs) in hereditary breast and ovarian cancer (HBOC) genes in pediatric malignancies by unselected genotyping identified 44% (12/27) of clinically unsuspected cases. Burden testing demonstrated considerable associations between monoallelic LP/PVs in five HBOC genes and ...
Katharina Daugs, Danielle Brandes, Layal Yasin, Ammarah Anwar, Jubayer Alam, Yash Prasad, Jil Bartrina y Manns, Melina Mescher, Ute Fischer, Arndt Borkhardt, Triantafyllia Brozou, Stefanie V. Junk   +11 more
wiley   +1 more source

Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement. [PDF]

Blood Adv
Muhsen IN, Roloff GW, Faramand R, Othman T, Valtis Y, Kopmar NE, Dekker SE, Connor M, Mercadal S, O'Connor TE, Dykes KC, Ahmed M, Jeyakumar N, Zhang A, Miller K, Sutherland KC, Guzowski C, Gupta VK, Majhail N, Battiwalla M, Solh MM, Malik SA, Mathews J, Oliai CH, Shaughnessy P, Mountjoy L, Lee CJ, Logan AC, Tsai SB, Leonard JT, Schwartz M, Sasine JP, Kumaran M, Frey N, Park JH, Koura D, Cassaday RD, Shah BD, Aldoss I, Muffly LS, Hill LC.   +40 more
europepmc   +1 more source

Socioeconomic background and childhood cancer survival in Germany: A nationwide assessment based on data from the German Childhood Cancer Registry

International Journal of Cancer, Volume 157, Issue 11, Page 2235-2247, 1 December 2025.
What's New? Significant advances in childhood cancer survival have transformed outcomes for many children globally. However, emerging evidence suggests that, even in settings with universal healthcare, these gains are not equally distributed. Here, the authors focused on childhood cancer survival in Germany, using data from the German Childhood Cancer ...
Maike Wellbrock, Arndt Borkhardt, Cécile M. Ronckers, Claudia Spix, Desiree Grabow, Anna‐Liesa Filbert, Daniel Wollschläger, Friederike Erdmann   +7 more
wiley   +1 more source

Blinatumomab Along With Combined Antifungal Agents for Refractory Adult Acute Lymphoblastic Leukemia With Invasive Aspergillosis: A Case Report. [PDF]

Clin Case Rep
Liu Y, Xia F, Cai W, Zhang Y, Zhu J, Shen Z, Li J, Yang Q, Qu Q, Chen J.   +9 more
europepmc   +1 more source

Secondary Malignancies Following CAR T‐Cell Therapy for B‐Cell Malignancies: A Retrospective Analysis

eJHaem, Volume 6, Issue 6, December 2025.
ABSTRACT Introduction Chimeric antigen receptor T‐cell (CART) therapy has shown clinical efficacy in relapsed and refractory large B‐cell malignancies. There is emerging data on the long‐term complications including risk of secondary malignancies. We aimed to describe the incidence and characteristics of secondary malignancies following CART therapy ...
Joanne Britto, Audrey Y. H. Dong, Gregory Pond, Tobias Berg, Kylie Lepic, Tom Kouroukis, Gwynivere A. Davies, Graeme Fraser, Ronan Foley, Amaris K. Balitsky   +9 more
wiley   +1 more source

Wernicke Encephalopathy in a Child With Acute Lymphoblastic Leukemia: A Case Report. [PDF]

Cancer Rep (Hoboken)
Shakibamaram G, Dolikhani M, Moussavi F, Sarraf S, Benyamin B, Advani S.   +5 more
europepmc   +1 more source

Nanodrug Delivery Systems for Acute Lymphoblastic Leukemia Therapy. [PDF]

Pharmaceuticals (Basel)
Yang A, Lu Y, Zhang Z, Wang J.
europepmc   +1 more source

Expression of Oct3/4 isoforms and its association with the risk of relapse in acute lymphoblastic leukemia. [PDF]

Biomed Rep
Organista-Nava J, Gómez-Gómez Y, Gómez-Sánchez CY, Salmerón-Bárcenas EG, Zubillaga-Guerrero MI, Rivera-Ramírez AB, Saavedra-Herrera MV, Alvarez-Palacios O, Torres-Rojas FI, Alarcón-Romero LDC, Illades-Aguiar B, Leyva-Vázquez MA.   +11 more
europepmc   +1 more source